摘要
目的: 观察米非司酮联合宫外孕Ⅱ号方加减治疗输卵管妊娠的临床疗效。方法: 对112例经HCG及B超确诊为输卵管妊娠患者, 按不同住院阶段所采用的不同治疗方法分为两组: 单用米非司酮治疗为A组, 应用米非司酮联合宫外孕Ⅱ号方加减治疗为B组。结果: A、B两组治愈率分别为86. 36%、97 .58%, B组治愈率高于A组, P<0 .05。B组病灶消失时间明显短于A组, P<0 .01。结论: 米非司酮与其抗宫内妊娠一样, 也能抗输卵管妊娠, 不损伤输卵管生理功能, 用于治疗宫外孕是一种简单、安全、有效的方法。早期诊断、及时治疗能有效提高输卵管妊娠药物保守治疗的成功率, 联合使用宫外孕Ⅱ号方加减, 能加速病灶吸收, 缩短疗程, 进一步提高治愈率。
Objective:To observe the clinical therapeutic effect of mifestone united plus minus recipeⅡfor ectopic pregnancy on oviducal pregnancy.Methods:112 patients with oviducal pregnancy diagnosed by HCG and ultrasonic B were divided into group A (simplex mifestone group) and group B (mifestone united plus minus recipeⅡfor ectopic pregnancy) according to different therapy and hospitalization duration.Results:The curative rate of group B (97.58%) was higher than that of group A(86.36%) ( P <0.05).The time of focus disappearance in group B was significantly shorter than that in group A ( P <0.01).Conclusion:As the other drugs for antiuterine pregnancy, mifestone could resist oviducal pregnancy without harm to tubal physiological function, which should be a simple, safe and effective method. Early diagnosis and timely treatment could enhance the success rate of oviducal pregnancy treated by drug conservative therapy. Mifestone united plus minus recipeⅡfor ectopic pregnancy could promote the absorption of focus, shorten treatment period and enhance the curative rate.
出处
《中国妇幼保健》
CAS
北大核心
2005年第11期1351-1353,共3页
Maternal and Child Health Care of China
关键词
米非司酮
宫外孕Ⅱ号方加减
输卵管妊娠
Mifestone
Plus minus recipeⅡfor ectopic pregnancy
Oviducal pregnancy
